A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
In other words, the Prime Minister will say that leaving the EU would not lead to a single EU law being abolished instantly.
Reclaim the Power stage a protest at Heathrow against a new runway or further airport expansion.
A colder night ahead as temperatures fall.